Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa
Open Forum Infectious Diseases · 30.06.2025 · 12 (7)
DOI: 10.1093/ofid/ofaf386 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 01.07.2025. Verfasst von Shabir A Madhi und 12 weiteren Autor:innen. Beteiligte Einrichtung: South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwat…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Vaccination during pregnancy to protect infants against respiratory syncytial virus (RSV) disease relies on transplacental transfer of RSV neutralizing antibodies. Observational natural history studies on correlations between RSV-specific antibody levels and infant protection have, however, had variable results.
Methods
This observational natural history study characterized RSV-specific neutralizing antibody levels and described infant RSV disease dynamics in South African and United States (US) maternal–infant pairs. Naturally acquired RSV serum neutralizing titers were determined from 726 pregnant individuals and their infants at birth and assessed in relationship to serum neutralizing titers conferred by serum palivizumab protective levels.
Results
In the absence of vaccination, we found no correlation between RSV neutralizing titers and infant protection against RSV-associated lower respiratory tract illness. South Africa versus US comparison revealed similar, broad distributions of maternal serum RSV neutralizing titers but lower transplacental transfer rates in South Africa (0.6 [95% confidence interval {CI}, .6–.7]) than the US (1.3 [95% CI, 1.1–1.4]) and high rates of community spread of infant asymptomatic RSV infection in South Africa versus the US.
Conclusions
These findings suggest that the effectiveness of maternal immunization against infant RSV relies on immunization shifting natural distribution of maternal RSV neutralizing titers into the protective range for infants, which is supported by efficacy demonstrated with RSV maternal immunization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
- Kaiser Permanente Vaccine Study Center, Division of Research, Oakland, California, USA.
- Pfizer Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA.
- Pfizer Vaccines, Pfizer Inc, Pearl River, New York, USA.
- Pfizer Vaccines, Pfizer Pharma GmbH, Berlin, Germany.
ORCID-Profile: Nicola P Klein, Agnieszka Zareba, Daniel A Scott, David Cooper, Kena A Swanson
Zitieren
APA
Madhi, S. A., Simões, E. A. F., Klein, N. P., Zareba, A., Dormitzer, P. R., Scott, D. A., Gurtman, A., Gruber, W. C., Jansen, K. U., Cooper, D., Cai, B., Schmoele-Thoma, B., & Swanson, K. A. (2025). Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa. Open Forum Infectious Diseases, 12(7). https://doi.org/10.1093/ofid/ofaf386
Vancouver
Madhi SA, Simões EAF, Klein NP, Zareba A, Dormitzer PR, Scott DA, et al. Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa. Open Forum Infectious Diseases. 2025;12(7). doi:10.1093/ofid/ofaf386
BibTeX
@article{Madhi2025,
author = {Madhi, Shabir A and Simões, Eric A F and Klein, Nicola P and Zareba, Agnieszka and Dormitzer, Philip R and Scott, Daniel A and Gurtman, Alejandra and Gruber, William C and Jansen, Kathrin U and Cooper, David and Cai, Bing and Schmoele-Thoma, Beate and Swanson, Kena A},
title = {Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {7},
doi = {10.1093/ofid/ofaf386}
}
EUVIMED